Cubist Systematic Strategies, LLC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 259 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 3.43 and the average weighting 0.4%.

Quarter-by-quarter ownership
Cubist Systematic Strategies, LLC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$1,702,840
-50.2%
23,149
-54.7%
0.01%
-50.0%
Q4 2022$3,417,087
+300.1%
51,154
+415.6%
0.02%
+300.0%
Q3 2022$854,000
-46.2%
9,922
-44.2%
0.01%
-50.0%
Q2 2022$1,586,000
+13.3%
17,777
+42.8%
0.01%
-16.7%
Q1 2022$1,400,000
+191.1%
12,447
+299.5%
0.01%
+140.0%
Q4 2021$481,000
+64.2%
3,116
+48.0%
0.01%
+25.0%
Q3 2021$293,000
-61.6%
2,106
-63.8%
0.00%
-55.6%
Q2 2021$763,000
-74.1%
5,814
-70.0%
0.01%
-76.3%
Q1 2021$2,950,000
+18.3%
19,349
-22.8%
0.04%
+11.8%
Q4 2020$2,493,000
+242.0%
25,068
+227.7%
0.03%
+209.1%
Q3 2020$729,000
-50.3%
7,649
-41.6%
0.01%
-56.0%
Q2 2020$1,466,000
-21.4%
13,103
-48.9%
0.02%
-50.0%
Q1 2020$1,864,000
+728.4%
25,630
+1089.3%
0.05%
+1150.0%
Q4 2019$225,000
-95.3%
2,155
-95.5%
0.00%
-95.7%
Q3 2019$4,753,000
+49.8%
47,748
+71.8%
0.09%
+62.1%
Q2 2019$3,173,000
+21.4%
27,798
+33.7%
0.06%
-31.8%
Q1 2019$2,614,000
+153.3%
20,796
+173.5%
0.08%
+73.5%
Q4 2018$1,032,000
+172.3%
7,603
+103.9%
0.05%
+63.3%
Q4 2016$379,000
+10.8%
3,728
+30.1%
0.03%
+50.0%
Q2 2016$342,000
-5.8%
2,865
-14.5%
0.02%
-4.8%
Q4 2015$363,0000.0%3,349
-28.8%
0.02%
+16.7%
Q1 2015$363,000
+45.2%
4,703
+0.1%
0.02%
+38.5%
Q4 2014$250,000
+2.9%
4,700
-9.2%
0.01%
-13.3%
Q3 2014$243,0005,1760.02%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q1 2017
NameSharesValueWeighting ↓
BVF INC/IL 2,626,160$138,136,00024.17%
KNOTT DAVID M 1,292,566$67,988,972,00013.87%
GROW Partners, LLC 200,000$10,520,0006.41%
Opaleye Management Inc. 90,000$4,860,000,0003.82%
OBERWEIS ASSET MANAGEMENT INC/ 213,317$11,220,0002.72%
First Light Asset Management, LLC 60,242$3,169,0002.69%
Timpani Capital Management LLC 98,956$5,205,0002.59%
Iguana Healthcare Management, LLC 75,000$3,945,0002.25%
Eventide Asset Management 134,400$7,069,0002.18%
ASHFORD CAPITAL MANAGEMENT INC 215,223$11,321,0002.16%
View complete list of LIGAND PHARMACEUTICALS INC shareholders